SCHEMBL18020134

SCHEMBL18020134

O=c1[nH]c(=O)c2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)ccc2[nH]1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 3/20 0.59
CA12 O43570 2/20 0.55
CA9 Q16790 2/20 0.55
KDM4E B2RXH2 2/20 0.55
PARP1 P09874 1/20 0.55
JAK2 O60674 1/20 0.46
PDE3B Q13370 2/20 0.44
NAPEPLD Q6IQ20 1/20 0.44
TNKS2 Q9H2K2 1/20 0.44
PLK4 O00444 1/20 0.44
CHEK1 O14757 1/20 0.44
PRKD3 O94806 1/20 0.44
MAP4K4 O95819 1/20 0.44
CDK1 P06493 1/20 0.44
LYN P07948 1/20 0.44
RET P07949 1/20 0.44
PIM1 P11309 1/20 0.44
FER P16591 1/20 0.44
CDK2 P24941 1/20 0.44
MARK3 P27448 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8900615 0.97 PDE3A (0.62) PDE3ACA12CA9KDM4EPARP1
SCHEMBL18020131 0.85 PDE3A (0.49) PDE3ACA12CA9KDM4EPARP1
SCHEMBL18020129 0.85 PARP1 (0.61) PDE3ACA12CA9KDM4EPARP1
SCHEMBL18019959 0.83 PDE3A (0.47) PDE3ACA12CA9KDM4EPARP1
SCHEMBL19850400 0.81 PDE3A (0.51) PDE3ACA12CA9KDM4EPARP1
SCHEMBL17979420 0.81 CA12 (0.49) PDE3ACA12CA9KDM4EPARP1
SCHEMBL31441277 0.81 CA12 (0.49) PDE3ACA12CA9KDM4EPARP1
SCHEMBL18020128 0.81 CA12 (0.47) PDE3ACA12CA9KDM4EPARP1
SCHEMBL18020146 0.80 PDE3A (0.50) PDE3ACA12CA9KDM4EPARP1
SCHEMBL14929461 0.80 CDK4 (0.54) KDM4EJAK2TNKS2GSK3BCDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3257093-B1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2021-07-07 EP disclosed
US-10249831-B2 Electronic device containing cyclic lactams MERCK PATENT GMBH (DE) 2019-04-02 US disclosed
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2018-02-08 US disclosed
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2018-02-08 US disclosed
WO-2016128103-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS MERCK PATENT GMBH (DE) 2016-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10249831-B2 Electronic device containing cyclic lactams OXA1L, UROD, MRPL21 PDE3A 1344/4885CA12 1575/4885CA9 1764/4885
US-20180040832-A1 ELECTRONIC DEVICE CONTAINING CYCLIC LACTAMS OXA1L, UROD, MRPL21 PDE3A 1344/4885CA12 1575/4885CA9 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.